Literature DB >> 2953668

Immunomodulation with liposomes: the immune response elicited by liposomes with entrapped dichloromethylene-diphosphonate and surface-associated antigen or hapten.

E Claassen, N Kors, N van Rooijen.   

Abstract

Macrophages in the murine spleen were eliminated by the intravenous administration of dichloromethylene-diphosphonate (DMDP) encapsulated in liposomes. The immune response against an antigen (bovine serum albumin, BSA) or hapten (dinitrophenyl, DNP) associated with the surface of the DMDP liposomes was studied. Significant effects of macrophage elimination on the primary (IgM), but not on the secondary (IgG), anti-BSA response were found. Dramatic effects on the response against liposome-associated DNP were observed in macrophage-depleted mice. The number of anti-DNP antibody-forming cells in the spleen decreased from 300 to 28 per section, and anti-DNP serum titres dropped to 12% of their normal values. Since a similar phenomenon was observed for TNP-Ficoll, a thymus-independent type-2 antigen (and not for thymus-dependent or thymus-independent type-1 antigens), we suggest that this response should be classified as thymus-independent type-2 on grounds of its in vivo behaviour. We conclude that adjuvant activity (and memory formation) of liposomes with antigen exposed on their surface occurs irrespective of the presence or absence of splenic macrophages, and that DMDP liposomes could be useful in drug targeting with antigenic liposomes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953668      PMCID: PMC1453280     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Characterization of non-lymphoid cells in the white pulp of the mouse spleen: an in vivo and in vitro study.

Authors:  P Eikelenboom
Journal:  Cell Tissue Res       Date:  1978-12-29       Impact factor: 5.249

2.  Liposomes as immunological adjuvants.

Authors:  A G Allison; G Gregoriadis
Journal:  Nature       Date:  1974-11-15       Impact factor: 49.962

3.  Enzyme immunoassay ELISA and EMIT.

Authors:  E Engvall
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Homing of liposomes to target cells.

Authors:  G Gregoriadis; E D Neerunjun
Journal:  Biochem Biophys Res Commun       Date:  1975-07-22       Impact factor: 3.575

5.  Periodate or glutaraldehyde for preparing peroxidase conjugates?

Authors:  D M Boorsma; J G Streefkerk
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

6.  Association of an albumin antigen with phosphatidylcholine liposomes alters the nature of immunoglobulins produced during the immune response against the antigen.

Authors:  N Van Rooijen; R Van Nieuwmegen
Journal:  Biochim Biophys Acta       Date:  1983-02-22

7.  Immunogenic properties of liposomal model membranes in mice.

Authors:  T Yasuda; G F Dancey; S C Kinsky
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

8.  The role of macrophages in promoting the antibody response mediated by liposome-associated protein antigens.

Authors:  P N Shek; S Lukovich
Journal:  Immunol Lett       Date:  1982       Impact factor: 3.685

9.  Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VI. Response in B-cell-defective CBA/N mice.

Authors:  H Snippe; A J van Houte; E F Lizzio; J M Willers; B Merchant
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

10.  Characterization of immunogenic properties of haptenated liposomal model membranes in mice. I. Thymus independence of the antigen.

Authors:  A J van Houte; H Snippe; J M Willers
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

View more
  9 in total

1.  Glycosyl receptors in macrophage subpopulations of rat spleen and lymph node. A comparative study using neoglycoproteins and monoclonal antibodies ED1, ED2 and ED3.

Authors:  G Harms; C D Dijkstra; M J Hardonk
Journal:  Cell Tissue Res       Date:  1990-10       Impact factor: 5.249

2.  Alveolar macrophages down-regulate local pulmonary immune responses against intratracheally administered T-cell-dependent, but not T-cell-independent antigens.

Authors:  T Thepen; K Hoeben; J Brevé; G Kraal
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

3.  In vitro complement-dependent binding and in vivo kinetics of pneumococcal polysaccharide TI-2 antigens in the rat spleen marginal zone and follicle.

Authors:  G Harms; M J Hardonk; W Timens
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Effects of chronic injection of sphingomyelin-containing liposomes on lymphoid and non-lymphoid cells in the spleen. Transient suppression of marginal zone macrophages.

Authors:  E Claassen; Y Westerhof; B Versluis; N Kors; M Schellekens; N van Rooijen
Journal:  Br J Exp Pathol       Date:  1988-12

5.  Immunopotentiation of the humoral response by liposomes: encapsulation versus covalent linkage.

Authors:  E Shahum; H M Thérien
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

6.  Increased adjuvant efficacy in stimulation of antibody responses after macrophage elimination in vivo.

Authors:  P P Leenaars; H F Savelkoul; C F Hendriksen; N Van Rooijen; E Claassen
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

7.  Marginal zone of the murine spleen in autotransplants: functional and histological observations in the response against a thymus-independent type 2 antigen.

Authors:  E Claassen; A Ott; W J Boersma; C Deen; M M Schellekens; C D Dijkstra; N Kors; N Van Rooijen
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

8.  Mechanism of follicular trapping: localization of immune complexes and cell remnants after elimination and repopulation of different spleen cell populations.

Authors:  J D Laman; N Kors; N Van Rooijen; E Claassen
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

9.  The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies.

Authors:  J M Brewer; J Richmond; J Alexander
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.